219
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Risk Genetic Variants (IL-10) for Osteoporosis in Han Population from Northwest China

, , , , , , , , & show all
Pages 1091-1102 | Received 15 Nov 2022, Accepted 04 Feb 2023, Published online: 14 Mar 2023

References

  • Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F. Secondary Osteoporosis. Endocr Rev. 2022;43(2):240–313. doi:10.1210/endrev/bnab028
  • Kanis JA, Hans D, Cooper C, et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int. 2011;22(9):2395–2411. doi:10.1007/s00198-011-1713-z
  • Sobh MM, Abdalbary M, Elnagar S, et al. Secondary osteoporosis and metabolic bone diseases. J Clin Med. 2022;11:9. doi:10.3390/jcm11092382
  • Yong EL, Logan S. Menopausal osteoporosis: screening, prevention and treatment. Singapore Med J. 2021;62(4):159–166. doi:10.11622/smedj.2021036
  • Collaborators GDaIIaP. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-7
  • Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22(3):465–475. doi:10.1359/jbmr.061113
  • Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2(6):285–289. doi:10.1007/BF01623184
  • Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ. Projection of osteoporosis-related fractures and costs in China: 2010–2050. Osteoporos Int. 2015;26(7):1929–1937. doi:10.1007/s00198-015-3093-2
  • Johnston CC Jr, Miller JZ, Slemenda CW, et al. Calcium supplementation and increases in bone mineral density in children. N Engl J Med. 1992;327(2):82–87. doi:10.1056/NEJM199207093270204
  • Hopper JL, Green RM, Nowson CA, et al. Genetic, common environment, and individual specific components of variance for bone mineral density in 10- to 26-year-old females: a twin study. Am J Epidemiol. 1998;147(1):17–29. doi:10.1093/oxfordjournals.aje.a009361
  • Morris JA, Kemp JP, Youlten SE, et al. An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet. 2019;51(2):258–266. doi:10.1038/s41588-018-0302-x
  • Zhu X, Bai W, Zheng H. Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications. Bone Res. 2021;9(1):23. doi:10.1038/s41413-021-00143-3
  • Teerlink CC, Jurynec MJ, Hernandez R, et al. A role for the MEGF6 gene in predisposition to osteoporosis. Ann Hum Genet. 2021;85(2):58–72. doi:10.1111/ahg.12408
  • Ni S, Shan F, Geng J. Interleukin-10 family members: biology and role in the bone and joint diseases. Int Immunopharmacol. 2022;108:108881. doi:10.1016/j.intimp.2022.108881
  • Kany S, Vollrath JT, Relja B. Cytokines in Inflammatory Disease. Int J Mol Sci. 2019;20:23. doi:10.3390/ijms20236008
  • Tural S, Alayli G, Kara N, Tander B, Bilgici A, Kuru O. Association between osteoporosis and polymorphisms of the IL-10 and TGF-beta genes in Turkish postmenopausal women. Hum Immunol. 2013;74(9):1179–1183. doi:10.1016/j.humimm.2013.03.005
  • Qiu J, Lu C, Zhang L, Zhou X, Zou H. Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors. Clin Rheumatol. 2022;41(9):2685–2693. doi:10.1007/s10067-022-06212-0
  • Tu MY, Han KY, Lan YW, et al. Association of TGF-β1 and IL-10 gene polymorphisms with osteoporosis in a study of Taiwanese osteoporotic patients. Genes. 2021;12:6. doi:10.3390/genes12060930
  • Park BL, Han IK, Lee HS, et al. Association of interleukin 10 haplotype with low bone mineral density in Korean postmenopausal women. J Biochem Mol Biol. 2004;37(6):691–699. doi:10.5483/bmbrep.2004.37.6.691
  • He J, Zou Y, Liu X, et al. Association of common genetic variants in pre-microRNAs and neuroblastoma susceptibility: a two-center study in Chinese children. Mol Ther Nucleic Acids. 2018;11:1–8. doi:10.1016/j.omtn.2018.01.003
  • Shah JA, Warr AJ, Graustein AD, et al. REL and BHLHE40 variants are associated with IL-12 and IL-10 responses and tuberculosis risk. J Immun. 2022;208(6):1352–1361. doi:10.4049/jimmunol.2100671
  • Stolf CS, Sacramento CM, Paz HES, et al. IL10 promoter rs6667202 polymorphism is functional in health but not in grade c periodontitis patients: a pilot study. J Periodontal Res. 2022;57(1):85–93. doi:10.1111/jre.12940
  • Vivas MC, Villamarín-Guerrero HF, Sanchez CA. Interleukin-10 (IL-10) 1082 promoter polymorphisms and plasma IL-10 levels in patients with bacterial sepsis. Rom J Intern Med. 2021;59(1):50–57. doi:10.2478/rjim-2020-0033
  • Chen HY, Chen WC, Hsu CM, Tsai FJ, Tsai CH. Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. Eur J Obstet Gynecol Reprod Biol. 2005;122(1):73–78. doi:10.1016/j.ejogrb.2005.02.003
  • Shahriyari E, Vahedi L, Roshanipour N, Jafarabadi MA, Khamaneh A, Laleh MG. Exploring the association of IL-10 polymorphisms in Behcet’s disease: a systematic review and meta-analysis. J Inflamm. 2019;16:26. doi:10.1186/s12950-019-0230-2
  • He S, Yang S, Zhao Q, et al. Association of IL4, IL6, and IL10 polymorphisms with pulmonary tuberculosis in a Tibetan Chinese population. Oncotarget. 2018;9(23):16418–16426. doi:10.18632/oncotarget.23995
  • Lv TT, Wu J, Li J, et al. Association of interleukin-10 gene single nucleotide polymorphisms with susceptibility to systemic lupus erythematosus in a Chinese population. Gene. 2018;642:549–554. doi:10.1016/j.gene.2017.11.072
  • Moghimi M, Ahrar H, Karimi-Zarchi M, et al. Association of IL-10 rs1800871 and rs1800872 polymorphisms with breast cancer risk: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2018;19(12):3353–3359. doi:10.31557/APJCP.2018.19.12.3353
  • Al-Rasheed A, Scheerens H, Rennick DM, Fletcher HM, Tatakis DN. Accelerated alveolar bone loss in mice lacking interleukin-10. J Dent Res. 2003;82(8):632–635. doi:10.1177/154405910308200812
  • Cohen SL, Moore AM, Ward WE. Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation. Inflamm Bowel Dis. 2004;10(5):557–563. doi:10.1097/00054725-200409000-00009
  • Gür A, Denli A, Nas K, et al. Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy. Rheumatol Int. 2002;22(5):194–198. doi:10.1007/s00296-002-0223-x
  • Yao X, Chen L, Xu H, Zhu Z. The association between serum uric acid and bone mineral density in older adults. Int J Endocrinol. 2020;2020:3082318. doi:10.1155/2020/3082318
  • Yan DD, Wang J, Hou XH, et al. Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population. Acta Pharmacol Sin. 2018;39(4):626–632. doi:10.1038/aps.2017.165
  • Lee HN, Kim A, Kim Y, Kim GT, Sohn DH, Lee SG. Higher serum uric acid levels are associated with reduced risk of Hip osteoporosis in postmenopausal women with rheumatoid arthritis. Medicine. 2020;99(24):e20633. doi:10.1097/MD.0000000000020633
  • Rattanawan C, Cheloh S, Maimahad A, Tayeh M. Prevalence and associated factors of Anemia among Muslim students, Nakhon Si Thammarat, Thailand: a cross-sectional study. Inquiry. 2021;58:469580211013476. doi:10.1177/00469580211013476
  • Hamali HA, Mobarki AA, Saboor M, et al. Prevalence of Anemia Among Jazan University Students. Int J Gen Med. 2020;13:765–770. doi:10.2147/IJGM.S275702
  • Cui R, Zhao Z, Fei Z, Li Y, Gao W. Anemia is related to osteoporosis in Chinese type 2 diabetic patients. Arch Osteoporos. 2021;16(1):161. doi:10.1007/s11657-021-01030-4
  • Korkmaz U, Korkmaz N, Yazici S, et al. Anemia as a risk factor for low bone mineral density in postmenopausal Turkish women. Eur J Intern Med. 2012;23(2):154–158. doi:10.1016/j.ejim.2011.11.009